Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma
Copyright © 2023. Published by Elsevier Inc..
BACKGROUND: Hepatocellular carcinoma (HCC) continues to pose a significant health challenge and is often diagnosed at advanced stages. Metabolic reprogramming is a hallmark of many cancer types, including HCC and it involves alterations in various metabolic or nutrient-sensing pathways within liver cells to facilitate the rapid growth and progression of tumours. However, the role of STAT3-NFκB in metabolic reprogramming is still not clear.
APPROACH AND RESULTS: Diethylnitrosamine (DEN) administered animals showed decreased body weight and elevated level of serum enzymes. Also, Transmission electron microscopy (TEM) analysis revealed ultrastructural alterations. Increased phosphorylated signal transducer and activator of transcription-3 (p-STAT3), phosphorylated nuclear factor kappa B (p-NFκβ), dynamin related protein 1 (Drp-1) and alpha-fetoprotein (AFP) expression enhance the carcinogenicity as revealed in immunohistochemistry (IHC). The enzyme-linked immunosorbent assay (ELISA) concentration of IL-6 was found to be elevated in time dependent manner both in blood serum and liver tissue. Moreover, immunoblot analysis showed increased level of p-STAT3, p-NFκβ and IL-6 stimulated the upregulation of mitophagy proteins such as Drp-1, Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK-1). Meanwhile, downregulation of Poly [ADP-ribose] polymerase 1 (PARP-1) and cleaved caspase 3 suppresses apoptosis and enhanced expression of AFP supports tumorigenesis. The mRNA level of STAT3 and Drp-1 was also found to be significantly increased. Furthermore, we performed high-field 800 MHz Nuclear Magnetic Resonance (NMR) based tissue and serum metabolomics analysis to identify metabolic signatures associated with the progression of liver cancer. The metabolomics findings revealed aberrant metabolic alterations in liver tissue and serum of 75th and 105th days of intervention groups in comparison to control, 15th and 45th days of intervention groups. Tissue metabolomics analysis revealed the accumulation of succinate in the liver tissue samples, whereas, serum metabolomics analysis revealed significantly decreased circulatory levels of ketone bodies (such as 3-hydroxybutyrate, acetate, acetone, etc.) and membrane metabolites suggesting activated ketolysis in advanced stages of liver cancer.
CONCLUSION: STAT3-NFκβ signaling axis has a significant role in mitochondrial dysfunction and metabolic alterations in the development of HCC.
| Errataetall: |
ErratumIn: Metabolism. 2024 Feb 2;153:155810. - PMID 38308944 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
|---|---|
| Enthalten in: |
Metabolism: clinical and experimental - 152(2024) vom: 15. März, Seite 155771 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ishteyaque, Sharmeen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alpha-Fetoproteins |
|---|
| Anmerkungen: |
Date Completed 08.02.2024 Date Revised 02.03.2024 published: Print-Electronic ErratumIn: Metabolism. 2024 Feb 2;153:155810. - PMID 38308944 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.metabol.2023.155771 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366747746 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366747746 | ||
| 003 | DE-627 | ||
| 005 | 20240303231905.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.metabol.2023.155771 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1315.xml |
| 035 | |a (DE-627)NLM366747746 | ||
| 035 | |a (NLM)38184165 | ||
| 035 | |a (PII)S0026-0495(23)00375-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ishteyaque, Sharmeen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2024 | ||
| 500 | |a Date Revised 02.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Metabolism. 2024 Feb 2;153:155810. - PMID 38308944 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
| 520 | |a BACKGROUND: Hepatocellular carcinoma (HCC) continues to pose a significant health challenge and is often diagnosed at advanced stages. Metabolic reprogramming is a hallmark of many cancer types, including HCC and it involves alterations in various metabolic or nutrient-sensing pathways within liver cells to facilitate the rapid growth and progression of tumours. However, the role of STAT3-NFκB in metabolic reprogramming is still not clear | ||
| 520 | |a APPROACH AND RESULTS: Diethylnitrosamine (DEN) administered animals showed decreased body weight and elevated level of serum enzymes. Also, Transmission electron microscopy (TEM) analysis revealed ultrastructural alterations. Increased phosphorylated signal transducer and activator of transcription-3 (p-STAT3), phosphorylated nuclear factor kappa B (p-NFκβ), dynamin related protein 1 (Drp-1) and alpha-fetoprotein (AFP) expression enhance the carcinogenicity as revealed in immunohistochemistry (IHC). The enzyme-linked immunosorbent assay (ELISA) concentration of IL-6 was found to be elevated in time dependent manner both in blood serum and liver tissue. Moreover, immunoblot analysis showed increased level of p-STAT3, p-NFκβ and IL-6 stimulated the upregulation of mitophagy proteins such as Drp-1, Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK-1). Meanwhile, downregulation of Poly [ADP-ribose] polymerase 1 (PARP-1) and cleaved caspase 3 suppresses apoptosis and enhanced expression of AFP supports tumorigenesis. The mRNA level of STAT3 and Drp-1 was also found to be significantly increased. Furthermore, we performed high-field 800 MHz Nuclear Magnetic Resonance (NMR) based tissue and serum metabolomics analysis to identify metabolic signatures associated with the progression of liver cancer. The metabolomics findings revealed aberrant metabolic alterations in liver tissue and serum of 75th and 105th days of intervention groups in comparison to control, 15th and 45th days of intervention groups. Tissue metabolomics analysis revealed the accumulation of succinate in the liver tissue samples, whereas, serum metabolomics analysis revealed significantly decreased circulatory levels of ketone bodies (such as 3-hydroxybutyrate, acetate, acetone, etc.) and membrane metabolites suggesting activated ketolysis in advanced stages of liver cancer | ||
| 520 | |a CONCLUSION: STAT3-NFκβ signaling axis has a significant role in mitochondrial dysfunction and metabolic alterations in the development of HCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Drp-1 | |
| 650 | 4 | |a Ketolysis | |
| 650 | 4 | |a Mitochondrial dysfunction | |
| 650 | 4 | |a NF-κβ | |
| 650 | 4 | |a NMR based serum and tissue metabolomics | |
| 650 | 4 | |a STAT3 | |
| 650 | 4 | |a Succinate | |
| 650 | 7 | |a alpha-Fetoproteins |2 NLM | |
| 650 | 7 | |a Interleukin-6 |2 NLM | |
| 650 | 7 | |a NF-kappa B |2 NLM | |
| 650 | 7 | |a STAT3 Transcription Factor |2 NLM | |
| 700 | 1 | |a Singh, Gurvinder |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Karan Singh |e verfasserin |4 aut | |
| 700 | 1 | |a Verma, Smriti |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Rakesh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Sen, Sumati |e verfasserin |4 aut | |
| 700 | 1 | |a Srivastava, Anurag Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Mitra, Kalyan |e verfasserin |4 aut | |
| 700 | 1 | |a Lahiri, Amit |e verfasserin |4 aut | |
| 700 | 1 | |a Bawankule, Dnyaneshwar U |e verfasserin |4 aut | |
| 700 | 1 | |a Rath, Srikanta Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Dinesh |e verfasserin |4 aut | |
| 700 | 1 | |a Mugale, Madhav Nilakanth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Metabolism: clinical and experimental |d 1952 |g 152(2024) vom: 15. März, Seite 155771 |w (DE-627)NLM000020761 |x 1532-8600 |7 nnns |
| 773 | 1 | 8 | |g volume:152 |g year:2024 |g day:15 |g month:03 |g pages:155771 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.metabol.2023.155771 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 152 |j 2024 |b 15 |c 03 |h 155771 | ||